2637485-14-2
Chemical Structure
Lp-PLA2-IN-12
- CAS No.: 2637485-14-2
- Formula:C24H23F2N5O3
- Molecular Weight:467.47
IUPAC Name: (6R,9aS)-3-((3,5-difluoro-4-((2-methylpyrimidin-5-yl)oxy)benzyl)oxy)-6,7,8,9-tetrahydro-1H,10H-6,9a-ethanopyrido[1',2':3,4]imidazo[1,2-c]pyrimidin-1-one
InChIKey: WNGGMNWILBZELI-GYCJOSAFSA-N
SMILES: O=C1N2C[C@]3(CC[C@H]4CCC3)N4C2=CC(OCC(C=C5F)=CC(F)=C5OC(C=N6)=CN=C6C)=N1
Biological Activity: Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative related diseases such as Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), or cardiovascular disease including atherosclerosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lp-PLA2-IN-12 | Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative related diseases such as Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), or cardiovascular disease including atherosclerosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
